Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002315428 | SCV000849301 | uncertain significance | Inborn genetic diseases | 2017-04-20 | criteria provided, single submitter | clinical testing | The p.N742S variant (also known as c.2225A>G), located in coding exon 1 of the RAI1 gene, results from an A to G substitution at nucleotide position 2225. The asparagine at codon 742 is replaced by serine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV002067040 | SCV002408329 | benign | not provided | 2023-12-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003938077 | SCV004747125 | uncertain significance | RAI1-related disorder | 2023-12-16 | no assertion criteria provided | clinical testing | The RAI1 c.2225A>G variant is predicted to result in the amino acid substitution p.Asn742Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0035% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |